Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 17;75(Suppl 3):S392-S401.
doi: 10.1093/cid/ciac536.

Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018

Marissa K Person  1 , Rachel Cook  2 , John S Bradley  3 , Nathaniel Hupert  4 , William A Bower  1 , Katherine Hendricks  1
Affiliations

Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018

Marissa K Person et al. Clin Infect Dis. .

Abstract

Background: Bacillus anthracis can cause anthrax and is a potential bioterrorism agent. The 2014 Centers for Disease Control and Prevention recommendations for medical countermeasures against anthrax were based on in vitro data and expert opinion. However, a century of previously uncompiled observational human data that often includes treatment and outcomes is available in the literature for analysis.

Methods: We reviewed treatment outcomes for patients hospitalized with anthrax. We stratified patients by meningitis status, route of infection, and systemic criteria, then analyzed survival by treatment type, including antimicrobials, antitoxin/antiserum, and steroids. Using logistic regression, we calculated odds ratios and 95% confidence intervals to compare survival between treatments. We also calculated hospital length of stay. Finally, we evaluated antimicrobial postexposure prophylaxis (PEPAbx) using data from a 1970 Russian-language article.

Results: We identified 965 anthrax patients reported from 1880 through 2018. After exclusions, 605 remained: 430 adults, 145 children, and 30 missing age. Survival was low for untreated patients and meningitis patients, regardless of treatment. Most patients with localized cutaneous or nonmeningitis systemic anthrax survived with 1 or more antimicrobials; patients with inhalation anthrax without meningitis fared better with at least 2. Bactericidal antimicrobials were effective for systemic anthrax; addition of a protein synthesis inhibitor(s) (PSI) to a bactericidal antimicrobial(s) did not improve survival. Likewise, addition of antitoxin/antiserum to antimicrobials did not improve survival. Mannitol improved survival for meningitis patients, but steroids did not. PEPAbx reduced risk of anthrax following exposure to B. anthracis.

Conclusions: Combination therapy appeared to be superior to monotherapy for inhalation anthrax without meningitis. For anthrax meningitis, neither monotherapy nor combination therapy were particularly effective; however, numbers were small. For localized cutaneous anthrax, monotherapy was sufficient. For B. anthracis exposures, PEPAbx was effective.

Keywords: anthrax; anthrax meningitis; antitoxin/antiserum; inhalation anthrax; treatment.

PubMed Disclaimer

References

    1. Beeching NJ, Dance DA, Miller AR, Spencer RC. Biological warfare and bioterrorism. BMJ 2002; 324:336–9. - PMC - PubMed
    1. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk Anthrax Outbreak of 1979. Science 1994; 266:1202–8. - PubMed
    1. Eitzen E, Takafuji E. Historical overview of biological warfare. In: Zajtchuck R, Bellamy R, Sidell F, Takafuji E, Franz D (eds.), Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of The Surgeon General at TMM Publications; 1997:415–23.
    1. Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8:1019–28. - PMC - PubMed
    1. World Health Organization . Health Aspects of Chemical and Biological Weapons: Report of a WHO Group of Consultants: World Health Organization, 1970.

Publication types

Supplementary concepts

Grants and funding